U.S. markets open in 4 hours 17 minutes

Bioventus Inc. (BVS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
14.61+0.29 (+2.03%)
At close: 4:00PM EDT

Bioventus Inc.

4721 Emperor Boulevard
Suite 100
Durham, NC 27703
United States
919 474 6700
http://www.bioventus.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full Time Employees700

Key Executives

NameTitlePayExercisedYear Born
Mr. Kenneth M. RealiCEO & Director1.33MN/A1966
Mr. Gregory O. AnglumSr. VP & CFO584.7kN/A1971
Ms. Alessandraa PavesioSr. VP & Chief Science Officer634.95kN/A1967
Mr. Anthony D'AdamioSr. VP & Gen. Counsel618.29kN/A1961
Mr. John E. NosenzoChief Commercial Officer907.28kN/A1958
Mr. Anthony JamesVP of Operations and QualityN/AN/AN/A
Mr. Miguel O. Beltran-DelgadoSr. VP of OperationsN/AN/AN/A
Ms. Katrina J. ChurchSr. VP & Chief Compliance OfficerN/AN/A1962
Mr. Jeff WelchVP of Bus. Devel.N/AN/AN/A
Mr. Leigh Ann StradfordSr. VP of HRN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company provides osteoarthritic joint pain treatment and joint preservation products, including Durolane, a single injection therapy; GELSYN-3, a three injection therapy; and SUPARTZ FX, a five injection therapy. It also offers bone graft substitutes comprising allograft-derived bone graft with growth factors, demineralized bone matrix, cancellous bone in different preparations, bioactive synthetics, collagen ceramic matrix, and bone marrow isolation systems. In addition, the company provides Exogen systems for the non-invasive treatment of established nonunion fractures and certain fresh fractures. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Corporate Governance

Bioventus Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.